Vischer, A.S.; Kuster, G.M.; Twerenbold, R.; Pfister, O.; Zhou, Q.; Villiger, A.; Poglitsch, M.; Krähenbühl, S.; Mayr, M.; Osswald, S.;
et al. Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients. Cells 2021, 10, 534.
https://doi.org/10.3390/cells10030534
AMA Style
Vischer AS, Kuster GM, Twerenbold R, Pfister O, Zhou Q, Villiger A, Poglitsch M, Krähenbühl S, Mayr M, Osswald S,
et al. Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients. Cells. 2021; 10(3):534.
https://doi.org/10.3390/cells10030534
Chicago/Turabian Style
Vischer, Annina S., Gabriela M. Kuster, Raphael Twerenbold, Otmar Pfister, Qian Zhou, Andrea Villiger, Marko Poglitsch, Stephan Krähenbühl, Michael Mayr, Stefan Osswald,
and et al. 2021. "Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients" Cells 10, no. 3: 534.
https://doi.org/10.3390/cells10030534
APA Style
Vischer, A. S., Kuster, G. M., Twerenbold, R., Pfister, O., Zhou, Q., Villiger, A., Poglitsch, M., Krähenbühl, S., Mayr, M., Osswald, S., Haschke, M., & Burkard, T.
(2021). Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients. Cells, 10(3), 534.
https://doi.org/10.3390/cells10030534